Friday, 15 March 2013

// // Leave a Comment

Alternative To Celexa?

By Kenneth Derek Shannon


Lexapro and Citalopram are both well known treatment options for people suffering from depressive disorders of many different types. You may also know Citalopram by its brand name of Celexa. Everyone should be aware of the fact that even though these two prescription medication have similarities in their structures, the actually have different effects and uses on the body.

Many medical professionals and doctors may prescribe either of these prescriptions to their clients that are suffering from anxiety disorders or depressive disorders. However, many researches have been performed comparing Celexa vs Lexapro. These studies show that they each have very different effects on their consumers.

Many folks that look at Citalopram and Lexapro side by side would realize that only one is approved by the food and drug administration for anxiety treatment. The one that is not approved for that particular type of use is Celexa.

Many of you are now freaking out due to the fact that you have been prescribed Citalopram for anxiety. Do not worry as this is common.

Celexa is also known to be available in the generic version of Citalopram. Lexapro does not have any generic versions on the market at this point in time.

The final decision of most researches on the topic will say that Lexapro is by far more effectively treating depression than its competitor. However, this is only an opinion and will very likely vary from one person to the next.

A large number of Celexa consumers are unable to switch over to taking Lexapro. This is due to the many differences of the two as well as the different side effects.

While the studies stand by Lexapro as a more efficient drug, there are still many folks that strongly believe in good old Citalopram. Keep in mind as well that Citalopram has been around for longer than the other as well so there is less chance of unknown Celexa side effects of this one rather than the other.




About the Author:



0 comments:

Post a Comment